Aggravation of the Existing Respiratory Diseases by the Loss or Difficulty in Supplying of Medicines and Medical Application: What Happened and What Measurements Should the Community and the Patient and His Family Do When the Medicines for the Existing Respiratory Disease Are Lost or Not Supplied?

  • Yuko KomaseEmail author
  • Takahiro Tsuburai
  • Naoya Hida
Part of the Respiratory Disease Series: Diagnostic Tools and Disease Managements book series (RDSDTDM)


Japan is subject to frequent natural disasters. In patients with respiratory diseases, continuous treatment is needed from the acute phase through the chronic phase of a disaster. When a disaster is divided into the acute, subacute, and chronic phases, medication shortages are expected during the acute phase, which delays the distribution of medications and prevents patients from obtaining enough medications. Given this premise, measures are needed to allow many patients to receive treatment equally during the acute phase. During patient education, medical professionals should encourage patients to stockpile necessary medications to be prepared for the acute phase of a disaster and should provide action plans for patients. During the subacute phase, medication stockpiles start to increase, thereby gradually allowing for the provision of regular treatment to patients. During the chronic phase, many residents tend to live in isolation, and patients need continued support.


Medication shortages Acute phase of a disaster Chronic phase of a disaster The distribution of medications Action plans for patients 


  1. 1.
    Kirch L, Luther S, Mucke P et al. WorldRiskReport- Analysis and prospects 2017. Bündnis Entwicklung Hilft. 2017. Accessed 6 Feb 2018
  2. 2.
    Japan Institute of Country-ology and Engineering. Accessed 6 Feb 2018 (in Japanese)
  3. 3.
    Early Warning Sub-Committee of the Inter-Ministerial Committee on International Cooperation for Disaster Reduction Government of Japan. Japan’s Natural Disaster Early Warning Systems and International Cooperative Efforts. Cabinet Office, Government of Japan. 2006. http://bousaigojp/kokusai/kyoryoku Accessed 6 Feb 2018 (in Japanese)
  4. 4.
    Nagamatsu S, Maekawa T, Ujike Y, et al. The earthquake and tsunami—observations by Japanese physicians since the11 March catastrophe. Crit Care. 2011;15:167.CrossRefGoogle Scholar
  5. 5.
    Otani Y, Ando T, Atobe K, et al. Comparison of two larger earthquakes: the 2008 Sichuan Earthquake and the 2011 East Japan Earthquake. Keio J Med. 2012;61:35–9.CrossRefGoogle Scholar
  6. 6.
  7. 7.
    Fukuhara A, Sato S, Uematsu M, et al. Impact of the 3.11 Disaster in Fukushima on Asthma Control. Am J Respir Crit Care Med. 2012;186:1309–10.CrossRefGoogle Scholar
  8. 8.
    Kobayashi S, Hanagama M, Yamanda S, Satoh H, Tokuda S, Kobayashi M, Ueda S, Suzuki S, Yanai M. The impact of a large-scale natural disaster on patients with chronic obstructive pulmonary disease: the aftermath of the 2011 Great East Japan Earthquake. Respir Investig. 2013;51:17–23.CrossRefGoogle Scholar
  9. 9.
    Yamanouchi K. Medical disease learned from the Great East Japan Earthquake-Feature, Treatment and Prevention; 2 Respiratory Diseases. Nippon Naika Gakkai Zasshi. 2014;103:551–6. in JapaneseCrossRefGoogle Scholar
  10. 10.
    Ohkochi S, Shibuya R, Yanai M, Nukiwa T. Deterioration in regional health status after the acute phase of a great disaster: respiratory physicians’ experiences of the Great East Japan Earthquake. Respir Investig. 2013;51:50–5.CrossRefGoogle Scholar
  11. 11.
    Ohkouchi S, et al. Fatal acute interstitial pneumonia a worker making chips from wooden debris generated by the Great East Japan earthquake and tsunami. Respir Investig. 2012;50(4):129.CrossRefGoogle Scholar
  12. 12.
    Japan Pharmaceutical Wholesalers Association. 2015. Accessed 6 Feb 2018 (in Japanese)
  13. 13.
    Fuse A, Shuto Y, Ando F, et al. Medical relief activities conducted by Nippon Medical School in the acute phase of the Great East Japan Earthquake 2011. J Nihon Med Sch. 2011;78:397–400.CrossRefGoogle Scholar
  14. 14.
    Suzuki M, Uwano C, Ohrui T, et al. Shelter-acquired pneumonia after a catastrophic earthquake in Japan. J Am Geriatr Soc. 2011;59:1968–70.CrossRefGoogle Scholar
  15. 15.
    Koudio IK, Alunid S, Kamigaki T, et al. Infectious diseases following natural disasters: prevention and control measures. Expert Rev Anti-Infect Ther. 2012;10:95–104.CrossRefGoogle Scholar
  16. 16.
    Aghababian RV, Teuacher J. Infectious diseases following major disasters. Ann Emergency Med. 1992;21:362–7.CrossRefGoogle Scholar
  17. 17.
    Mikasa K, Aoki N, Aoki Y, et al. Infectious Diseases: The Japanese Association for Infectious Diseases/Japanese Society of Chemotherapy—The JAID/JSC Guide to Clinical Management of Infectious Disease/Guideline-preparing Committee Respiratory Infectious Disease WG. J Infect Chemotherapy. 2016;22:S1–S65.CrossRefGoogle Scholar
  18. 18.
    Yokohama Pharmaceutical Association. Accessed 6 Feb 2018 (in Japanese)
  19. 19.
    Oita Pharmaceutical Association. Accessed 6 Feb 2018 (in Japanese)
  20. 20.
    Adachi Y, Fujiwara T. Dealing with asthma/allergy ailments in children during a disaster: a report on the Great East Japan Earthquake and proposals for future actions—5. Countermeasure pamphlet (2) Asthma. Jpn J Pediatr Allergy Clin Immunol. 2011;25:742–5.CrossRefGoogle Scholar
  21. 21.
    Matsui T. Dealing with asthma/allergy ailments in children during a disaster: a report on the Great East Japan Earthquake and proposals for future actions—4. Local assistance. Jpn J Pediatr Allergy Clin Immunol. 2011;25:734–8.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.Department of Respiratory Internal MedicineSt. Marianna University, School of Medicine, Yokohama-City Seibu HospitalYokohamaJapan

Personalised recommendations